Effectiveness of Spirometry as a Motivational Tool to Quit Smoking (ESPIMOAT)

January 26, 2015 updated by: Mº Isabel Irizar Aramburu, Basque Health Service

Effectiveness of Spirometry and the Report of Spirometric Test Results by a Primary Care Physician on Smoking Cessation Rate in Adult Smokers: a Randomized Controlled Trial.

The aim of the study is to asses the efficacy of the spirometry and a minimal smoking cessation counselling intervention to quit smoking after a year in patients older than 40 years, smokers of more than 10 packs-year and without a chronic obstructive pulmonary disease (COPD) diagnosis.

Study Overview

Study Type

Interventional

Enrollment (Actual)

335

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Alava 45
      • Vitoria-Gasteiz, Alava 45, Spain, 1006
        • Basque Health Service

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

- Active smokers over 40 years and more than 10 pack-years

Exclusion Criteria:

  • Previous diagnosis of respiratory disease (asthma, COPD, interstitial lung disease) that cause alteration of spirometric pattern.
  • Patients with limitations in performing spirometry
  • Age greater than 80 years
  • Institutionalized patients
  • Patients with a life expectancy less than 1 year
  • Spirometry in the past 2 years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Spirometry and a brief advice to quit smoking

Intervention group:

The intervention consists of completing a questionnaire and undergo spirometry with bronchodilator test by a trained nurse. Later, the patients receives a brief advice to quit smoking and a report of the spirometry results by their family doctor.

During a year, recruitment for active smoker patients was done by doctors in primary care medical offices. In the intervention group, after been randomized, one trained nurse completed the questionnaires and did the spirometry with bronchodilator test and set a date with its family doctor who did a minimal smoking cessation counselling intervention and informed the patients about the spirometry results according to established protocol.
Active Comparator: Brief advice to quit smoking

Control group:

Patients in the control group complete a questionnaire by a nurse and then receive a brief advice to quit smoking by their family doctor.

During a year, recruitment for active smokers patients occurred through doctors in primary care medical offices. After be randomized, in de control group, a nurse complete the questionnaires. Below, patients go to the family doctor who will do a minimal smoking cessation counselling intervention.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The primary measure of results will be the differences in smoking cessation rates between intervention and control groups
Time Frame: 12 months after been conducted the intervention
In all patients who report smoking withdrawal, smoking cessation will be confirmed by air carbon monoxide concentration.
12 months after been conducted the intervention

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reduce the number of cigarettes among those who continue smoking
Time Frame: 12 months after been conducted the intervention
One secondary outcome will be to reduce the number of cigarettes. In all patients who continue smoking will be recorded the number of cigarettes smoked per day currently
12 months after been conducted the intervention
Increase smoking abstinence rates in patients with COPD
Time Frame: 12 months after been conducted the intervention
Evaluate the differences in smoking cessation rates between patients with COPD and those without.
12 months after been conducted the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mª Isabel Irizar Aramburu, Osakidetza

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2012

Primary Completion (Actual)

December 1, 2013

Study Completion (Actual)

January 1, 2015

Study Registration Dates

First Submitted

March 27, 2013

First Submitted That Met QC Criteria

March 29, 2013

First Posted (Estimate)

April 1, 2013

Study Record Updates

Last Update Posted (Estimate)

January 27, 2015

Last Update Submitted That Met QC Criteria

January 26, 2015

Last Verified

January 1, 2015

More Information

Terms related to this study

Other Study ID Numbers

  • 2011111013
  • KRONIK11/071 - EJGV 2011111013 (Other Identifier: KRONIKGUNE - EUSKO JAURLARITZA/GOBIERNO VASCO)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on Spirometry and a brief advice to quit smoking

3
Subscribe